THE HEPATOBILIARY PATHOLOGY IN PATIENTS WITH OBESITY
The hepatobiliary system is the most vulnerable area in patients with obesity. The visceral fatty tissue releases large amount of biologically active substances determining formation and characteristics of course of such diseases as biliary dysfunctions, cholelithiasis, and non-alcoholic fatty disease of liver. The therapy of pathology of this kind is to be based on the combination of non-medicamental and medicamental methods. The impact on insulin resistance promotes both normalization of metabolic disorders and treatment of pathology of liver and bile-excreting tracts.